🔎 Trials Near Me

Home › Overweight › California › Concord

Pag-aaral pangklinika para sa Overweight sa Concord, CA

16 pag-aaral para sa Overweight ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Concord (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

Nagre-recruitPhase 3
  • Diablo Clinical Research, Inc., Walnut Creek · 5 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07533175

Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes

Nagre-recruitPhase 2
  • Diablo Clinical Research - Flourish Research, Walnut Creek · 5 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07685808

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Nagre-recruitPhase 2
  • John Muir Health - Concord /ID# 282469, Concord
  • Diablo Clinical Research /ID# 282530, Walnut Creek · 5 mi ang layo
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07752979

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

Nagre-recruitPhase 3
  • Diablo Clinical Research, Inc., Walnut Creek · 5 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07720271

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

Nagre-recruitPhase 3
  • Diablo Clinical Research, Inc., Walnut Creek · 5 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07595549

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

Nagre-recruitPhase 3
  • Diablo Clinical Research, Inc., Walnut Creek · 5 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07794579

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

Nagre-recruitPhase 3
  • Research Site, Walnut Creek · 5 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07776509

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Nagre-recruitPhase 3
  • Diablo Clinical Research, Inc., Walnut Creek · 5 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07282600

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Nagre-recruitPhase 3
  • Diablo Clinical Research, Walnut Creek · 5 mi ang layo
Edad 45 hanggang 99 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07037433

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

Nagre-recruitPhase 3
  • Diablo Clinical Research, Inc., Walnut Creek · 5 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07353931

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Nagre-recruitPhase 3
  • Research Site, Walnut Creek · 5 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07784270

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Nagre-recruitPhase 2
  • Diablo Clinical Research, Inc., Walnut Creek · 5 mi ang layo
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07589608

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

Nagre-recruitPhase 3
  • Diablo Clinical Research, Inc., Walnut Creek · 5 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT07351045

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Nagre-recruitPhase 2
  • Diablo Clinical Research, Inc., Walnut Creek · 5 mi ang layo
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 8, 2026 · NCT06143956

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Nagre-recruitPhase 3
  • Diablo Clinical Research, Walnut Creek · 5 mi ang layo
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07684235

Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events

Nagre-recruitPhase 1
  • Diablo Clinical Research, Inc., Walnut Creek · 5 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 25, 2026 · NCT07607587

Pag-aaral para sa Overweight sa ibang lungsod

Iba pang pag-aaral sa Concord

Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.